I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Susca, Sara
33
results:
Search for persons
X
Format
Online (33)
Mediatypes
Articles (Online) (20)
Bookchapter (Online) (2)
OpenAccess-fulltext (11)
Sorted by: Relevance
Sorted by: Year
?
1
Anti-IL23 in inflammatory bowel disease patients with derma..:
Ribaldone, Davide Giuseppe
;
Palumbo, Andrea
;
Susca, Sara
...
Digestive and Liver Disease. 56 (2024) 1 - p. 220-222 , 2024
Link:
https://doi.org/10.1016/..
?
2
Clinical characteristics and response to biological therapi..:
Mastorino, Luca
;
Dapavo, Paolo
;
Macagno, Nicole
...
International Journal of Dermatology. , 2024
Link:
https://doi.org/10.1111/..
?
3
Drug Survival, Safety, and Effectiveness of Secukinumab for..:
Mastorino, Luca
;
Dapavo, Paolo
;
Cariti, Caterina
...
Journal of Personalized Medicine. 14 (2024) 7 - p. 718 , 2024
Link:
https://doi.org/10.3390/..
?
4
Drug survival und klinische Wirksamkeit von Secukinumab, Ix..:
Mastorino, Luca
;
Dapavo, Paolo
;
Susca, Sara
...
JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 22 (2024) 1 - p. 34-44 , 2024
Link:
https://doi.org/10.1111/..
?
5
Drug survival and clinical effectiveness of secukinumab, ix..:
Mastorino, Luca
;
Dapavo, Paolo
;
Susca, Sara
...
JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 22 (2023) 1 - p. 34-42 , 2023
Link:
https://doi.org/10.1111/..
?
6
Comparison between brodalumab, secukinumab and ixekizumab e..:
Mastorino, Luca
;
Cariti, Caterina
;
Susca, Sara
...
Experimental Dermatology. 32 (2023) 9 - p. 1591-1594 , 2023
Link:
https://doi.org/10.1111/..
?
7
Effectiveness of Brodalumab on Scalp, Palmoplantar, and Gen..:
Mastorino, Luca
;
Celoria, Valentina
;
Macagno, Nicole
...
Dermatologic Therapy. 2023 (2023) - p. 1-5 , 2023
Link:
https://doi.org/10.1155/..
?
8
SPHEREx Preliminary Mission Overview:
, In:
2023 IEEE Aerospace Conference
,
Alibay, Farah
;
Sindiy, Oleg V.
;
Jansma, P. A. Trisha
... - p. 1-18 , 2023
Link:
https://doi.org/10.1109/..
?
9
Risankizumab shows high efficacy and maintenance in improve..:
Mastorino, Luca
;
Susca, Sara
;
Megna, Matteo
...
Dermatologic Therapy. 35 (2022) 5 - p. , 2022
Link:
https://doi.org/10.1111/..
?
10
Tildrakizumab in real‐life shows good efficacy in moderate‐..:
Mastorino, Luca
;
Cariti, Caterina
;
Susca, Sara
...
Dermatologic Therapy. 35 (2022) 11 - p. , 2022
Link:
https://doi.org/10.1111/..
?
11
A new suture technique for flap closure in dermatologic sur..:
Parietti, Michele
;
Susca, Sara
;
Ribero, Simone
Journal of the American Academy of Dermatology. 87 (2022) 5 - p. e141-e142 , 2022
Link:
https://doi.org/10.1016/..
?
12
Drug survival and efficacy of anti-interleukin 23 biologics..:
Roccuzzo, Gabriele
;
Mastorino, Luca
;
Susca, Sara
...
Clinical and Experimental Dermatology. 48 (2022) 4 - p. 379-381 , 2022
Link:
https://doi.org/10.1093/..
?
13
"Superresponders" at biologic treatment for psoriasis: A co..:
Mastorino, Luca
;
Susca, Sara
;
Cariti, Caterina
...
Experimental Dermatology. 32 (2022) 12 - p. 2187-2188 , 2022
Link:
https://doi.org/10.1111/..
?
14
Europa Clipper: MBSE Proving Ground:
, In:
2021 IEEE Aerospace Conference (50100)
,
Bayer, Todd
;
Day, John
;
Dodd, Emma
... - p. 1-19 , 2021
Link:
https://doi.org/10.1109/..
?
15
Dual‐targeted therapy with apremilast and vedolizumab in py..:
Vernero, Marta
;
Ribaldone, Davide Giuseppe
;
Cariti, Caterina
...
The Journal of Dermatology. 47 (2020) 6 - p. , 2020
Link:
https://doi.org/10.1111/..
1-15